This video provides highlights from the first half of the Invivoscribe corporate workshop, MRD Solutions for the Studies of Hematologic Malignancies, at AMP 2016 in Charlotte, North Carolina, USA. The speaker Dr. Maria Arcila, the Deputy Chief of Molecular Diagnostic Service & Medical Director of Molecular Hematopathology at Memorial Sloan Kettering Cancer Center, discusses her labs approach to study minimal residual disease (MRD) with the use the NGS-based LymphoTrack® IGH and TRG Assays.